Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Disease Diagnosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01527916
What this trial is testing

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 438
Testing effectiveness (Phase 2)Active Not RecruitingNCT06544616
What this trial is testing

JNJ-64042056 in Participants With Preclinical Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen Pharmaceutica N.V., Belgium 55
Post-approval studies (Phase 4)Study completedNCT00267163
What this trial is testing

Brain Imaging and Mental Disorders of Aging Intervention

Who this might be right for
Cognition Disorders
National Institute on Aging (NIA) 64
Testing effectiveness (Phase 2)UnknownNCT02833792
What this trial is testing

Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease

Who this might be right for
Alzheimer Dementia
Stemedica Cell Technologies, Inc. 40
Not applicableUnknownNCT05891444
What this trial is testing

Effect of Transcranial Random Noise (tRNS) for Early Alzheimer's Disease

Who this might be right for
Transcranial Random NoiseElectroencephalographyAlzheimer Disease
Anhui Medical University 40
Not applicableStudy completedNCT01998711
What this trial is testing

Impact of a Memory Group for Older Adults Reporting Memory Difficulties

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
Bayside Health 62
Post-approval studies (Phase 4)Study completedNCT02553928
What this trial is testing

Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer

Who this might be right for
Alzheimer Dementia (AD)
H. Lundbeck A/S 62
Not applicableStudy completedNCT03130036
What this trial is testing

Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Risk Factors for Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment
Wake Forest University Health Sciences 42
Not applicableActive Not RecruitingNCT06960915
What this trial is testing

Efficacy of Virtual Reality Reminiscence Therapy in Nursing Home Residents With Alzheimer's Disease or Related Diseases

Who this might be right for
Virtual RealityReminiscence TherapyNursing Home+2 more
Centre Hospitalier Universitaire, Amiens 50
Not applicableLooking for participantsNCT06481878
What this trial is testing

Validation of an Alzheimer's Disease Marker by Fecal Assay of Amyloid Peptides and Tau Proteins

Who this might be right for
Alzheimer Disease
University Hospital, Grenoble 115
Not applicableStudy completedNCT03384043
What this trial is testing

Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseCognitive Impairment, MildDementia, Mild
Baylor University 52
Testing effectiveness (Phase 2)Study completedNCT04070378
What this trial is testing

Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Marc L Gordon, MD 16
Not applicableStudy completedNCT01081743
What this trial is testing

Effectiveness of Care Management in Alzheimer Patients

Who this might be right for
Alzheimer Disease or Associated DisorderMild to Moderately Severe Dementia
Institut de Sante Publique, d'Epidemiologie et de Developpement 270
Large-scale testing (Phase 3)Study completedNCT00095719
What this trial is testing

Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia

Who this might be right for
DementiaAlzheimer's Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 125
Large-scale testing (Phase 3)Study completedNCT04669028
What this trial is testing

NE3107 in Probable Alzheimer's Disease

Who this might be right for
Alzheimer Disease
BioVie Inc. 439
Not applicableActive Not RecruitingNCT03507257
What this trial is testing

Longitudinal Early-onset Alzheimer's Disease Study Protocol

Who this might be right for
Early Onset Alzheimer DiseaseAlzheimer DiseaseMild Cognitive Impairment
Indiana University 850
Early research (Phase 1)Study completedNCT00479219
What this trial is testing

Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 17
Testing effectiveness (Phase 2)Study completedNCT00812565
What this trial is testing

Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Octapharma 58
Not applicableUnknownNCT04277767
What this trial is testing

The Role of Ophthalmologic Tests and EEG Imaging in Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment
Zhongshan Ophthalmic Center, Sun Yat-sen University 60
Early research (Phase 1)Study completedNCT00499200
What this trial is testing

Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor Occupancy

Who this might be right for
Alzheimer's Disease
Wyeth is now a wholly owned subsidiary of Pfizer 42
Next Page